Journal: Critical Care and Resuscitation
Article Title: An in-vitro study to characterise analytical interference caused by sodium ascorbate with point-of-care measurement of lactate and glucose
doi: 10.1016/j.ccrj.2026.100174
Figure Lengend Snippet: Measured plasma lactate at baseline and target ascorbate levels for devices Roche colorimetric (SA Pathology; open circles), Radiometer ABL800 blood gas analyser (squares) and StatProfile Prime Plus blood gas analyser (diamonds). Data are mean (95% CI) estimated by GEE model; device × target interaction effect p<0.0001, with between-device differences at all target levels p<0.05.
Article Snippet: Baseline and spiked blood samples were immediately analysed at the bedside with several POC devices, based on availability, including the RAPIDPoint® 500 Blood gas system (Siemens HealthCare, Erlangen, Germany), Epoc® Blood analysis system (Siemens HeathCare, Erlangen, Germany), Radiometer ABL800 blood gas analyser (Radiometer, Copenhagen, Denmark), StatProfile® Prime Plus blood gas analyser (Nova Biomedical, Waltham, USA), i-STAT 1® blood analyser (Abbott Laboratories, North Chicago, USA), HemoCue® Glucose 201 (HemoCue, Angelholm, Sweden), FreeStyle Optium Neo (Abbott, Illinois, USA), StatStrip Xpress® lactate system (Nova Biomedical, Waltham, USA) and the StatStrip Xpress® glucose meter (Nova Biomedical, Waltham, USA) ( ).
Techniques: Clinical Proteomics